Ketogenic Diet May Harm Small Intestine While Benefiting Colon, Study Finds

The popular ketogenic diet, often lauded for weight loss and potential cancer prevention, may have a complex and even contradictory impact on the human gut, according to a new study. Researchers found that the same diet could inhibit tumor growth in the colon while simultaneously increasing the risk of tumors in the small intestine.

The study, conducted by researchers at the Massachusetts Institute of Technology (MIT) and published in the journal Nature, utilized mice genetically predisposed to intestinal cancer. The findings revealed a significant increase in small intestine tumors among mice on a ketogenic diet. This contrasts with previous research indicating that the same diet could reduce colon tumor formation, highlighting a potential divergence in how adjacent organs respond to dietary changes.

Initially, the research team hypothesized that ketone bodies, a byproduct of fat metabolism in ketogenic diets, were the primary factor. However, further analysis pointed to the high fat content itself as the key influencer in the small intestine. When small intestine cells metabolize large amounts of fat, it stimulates intestinal stem cells, accelerating cell renewal and repair. While this heightened stem cell activity can aid in tissue repair, it also increases the likelihood of genetic mutations and tumor development.

Researchers emphasize that these findings are derived from animal models with a high genetic risk for cancer and cannot be directly extrapolated to humans. They stress the need for further human studies to confirm these effects and to understand the precise biological mechanisms behind the opposing reactions in the colon and small intestine. This understanding is crucial for developing future cancer prevention strategies and personalized dietary recommendations.